OBJECTIVE: Neurally adjusted ventilatory assist (NAVA) synchronizes spontaneous respiratory effort with mechanical ventilation. Electrodes detect the electrical activity of the diaphragm (Edi) and transmit this information to the ventilator, allowing the patient to determine their own respiratory rate (RR), peak pressures, and inspiratory and expiratory times in synchrony with the ventilator. The objective of this study was to evaluate if premature neonates ventilate as effectively on NAVA as compared to pressure control ventilation (PCV). STUDY DESIGN: Five ventilated neonates were enrolled (gestational age 25-29 weeks). Each neonate was ventilated on NAVA for 4 h, then switched to PCV for another 4 h. The cycle was repeated three times. Ventilatory parameters were averaged every 30 min to collect eight time points for each ventilatory mode. Data were analyzed using the mixed effects model procedure, utilizing the least-squares means (Po0.05). RESULT: When compared to PCV, neonates ventilated with NAVA had lower peak inspiratory pressures (PIP), fraction of inspired oxygen (FiO 2 ), transcutaneous PCO 2 Edi peak and RR. There was an increase in expiratory tidal volume (TV), compliance and Edi minimum. Despite lower PIP and RR, partial pressure of CO 2 (PCO 2 ) was lower when ventilated on NAVA. There was no difference in mean airway pressure. CONCLUSION: Premature neonates ventilated with NAVA required less PIP, FiO 2 and RR to achieve lower PCO 2 and better compliance compared with PCV.
INTRODUCTION
Neurally adjusted ventilatory assist (NAVA) is a new mode of synchronized mechanical ventilation, which utilizes changes in the electrical activity of the diaphragm (Edi) to trigger the ventilator. Current ventilators use a flow trigger to initiate a mechanical breath, which have a set tidal volume (TV) or peak inspiratory pressure (PIP), and inspiratory and expiratory time that may or may not be in synchrony with the patient. False and missed triggers are common problems with this type of system. 1, 2 Alternatively, NAVA utilizes a special nasogastric catheter, with embedded electrodes positioned at the level of the diaphragm, to measure the amplitude, duration and frequency of the Edi and transmits this information to the ventilator. The Edi peak represents the neural inspiratory effort and is the amount of electrical activity needed to generate each breath. The Edi minimum (min) is the electrical activity responsible for maintaining the functional residual capacity of the lung and preventing derecruitment. The Edi signal is converted into a pressure proportional to the change in Edi and allows the ventilator to be in synchrony with the patient who determines the PIP, respiratory rate (RR), inspiratory and expiratory times on a breath-by-breath basis. 3, 4 There are currently limited data available about the use of NAVA in neonates 5 À 12 and only one retrospective study about the use of NAVA in premature neonates for longer than a few hours. 13 This current study was designed to prospectively compare NAVA ventilation to pressure control ventilation (PCV) in extremely premature neonates.
METHODS
This was a prospective crossover comparison study conducted in the Neonatal Intensive Care Unit at Toledo Children's Hospital. The study was approved by the Institutional Review Board of Toledo Children Hospital and a two-parent informed consent was obtained for all subjects. Very lowbirth-weight, premature neonates who were on conventional ventilation were changed to NAVA ventilation on the Servo-I ventilator (Maquet, Solna, Sweden) for 4 h. The initial NAVA level was chosen when the patient was on conventional ventilation by using the NAVA preview screen and matching the NAVA pressure estimate with the peak pressure in conventional ventilation per company guidelines. This level was kept constant while on NAVA. NAVA level is a conversion factor that allows the neonate to convert the Edi signal into a proportional pressure on a breathby-breath basis. 3 The patient adjusts their own Edi, utilizing their biological feedback pathways, to direct the ventilator in order to deliver the desired pressure. The actual NAVA level makes little difference to the ventilator pressure delivered, but determines the amount of work being done by the ventilator versus the patient. A higher NAVA level unloads the patient's work to the ventilator, allowing it to function as an accessory diaphragm and assist the patient. A lower NAVA level allows the patient to assume more of the ventilatory workload. 14, 15 All neonates remained on a positive end-expiratory pressure (PEEP) of 5 cm H 2 O throughout the study. Backup settings on NAVA were chosen to match the preNAVA ventilator settings.
The neonates were then switched to PCV for 4 h. To determine a starting PIP on PCV, the PIP was established from an estimate of the average PIP over the last 30 min on NAVA. The PIP and fraction of inspired oxygen (FiO 2 ) were adjusted to keep the transcutaneous PCO 2 (TcpCO 2 , SenTec Digital Monitoring System Ag, Therwil, Switzerland) and O 2 saturation (Sat, Phillips Monitor, Andover, MA, USA) within a predetermined range (TcpCO 2 55-60 and SPO 2 86-95%). In PCV the peak pressure was changed only if 1 Department of Neonatology, Toledo Children Hospital, Toledo, OH, USA; the partial pressure of CO 2 (PCO 2 ) was 460. The PIP was increased by one every few minutes until the PCO 2 was o60 again. Ifthe PCO 2 became o55 the PIP was decreased in the same way. The minimum backup rate on PCV was set at 40 breaths per min and increased only if the patient was having oxygen desaturations or bradycardia. The flow trigger sensitivity was kept constant at 5 (50% of the bias flow of 0.5 l.p.m.) and the inspiratory time was set at 0.35 s. The cycle was repeated three times for a total study time of 24 h. This resulted in each patient having three crossovers from NAVA to PCV and two crossovers from PCV to NAVA. PIP, mean airway pressure (MAP), RR, FiO 2 , compliance, and the Edi peak and min were measured and stored in 1-min increments on the Servo-I ventilator and then downloaded to Excel for statistical analysis. Every hours of continuous data were averaged every 30 min. TcpCO 2 was recorded every 30 min. The number of desaturation and bradycardic events were collected in both PCV and NAVA.
Data were analyzed using Proc Mixed (mixed effects model procedure) in SAS (Cary, NC, USA) with treatment (NAVA versus PCV), round (NAVA 1 versus PCV 1) and time as fixed effects, and subject as a random effect. Only pairwise interactions of round and time with treatment were considered and these interactions were considered first. If an interaction term was not statistically significant it was removed and the model was rerun. If an interaction term was statistically significant, it and its associated main effects were left in the model. If interactions and main effects were not statistically significant, they were removed from the model. The main question of treatment effect was decided by a t-statistic derived from the 'least-squares means' option in Proc Mixed in SAS. Po0.05 was considered significant.
RESULTS
Five low birth premature neonates (resulting in 15 crossover studies from NAVA to PCV and 10 crossover studies from PCV to NAVA) were enrolled in the study. All mothers had received prenatal steroids. Four neonates were born by C-section. Mean gestational age was 26.2 ± 0.8 weeks (range 25-29 weeks) and mean birth weight was 697 ± 314 g (range 370-1140 g). Mean chronologic age at study was 24±10 days (range 6-34 days) and mean weight at study was 850 ± 338 g (range 545-1380 g). All neonates received surfactant. All were still ventilator dependent at the time of the study and were considered to have pulmonary insufficiency of prematurity. All were on caffeine citrate to augment spontaneous respiratory drive during NAVA and none had received postnatal steroids. Four out of five neonates were on synchronized intermittent mandatory ventilation (PCV) with pressure support ventilation (PSV) (PIP 14 À 22 cmH 2 O, PEEP 4-6 cmH 2 O, RR 40-60 breaths per min, FiO 2 0.21-0.60) and one was on NAVA (NAVA level 1) prior to the study. All were stable with baseline TcpCO 2 in the range of 55-60 mm Hg. During the NAVA periods, the NAVA level ranged between 1 and 2 cm H 2 O mV -1 but remained constant for each neonate. Table 1 shows all measured variables averaged over 12 h on NAVA and on PCV. All measured parameters were statistically different except for MAP. Overall, when comparing 12 h on PCV with 12 h on NAVA, neonates ventilated with PCV had 11% higher average PIP and 8% higher RR. Despite higher PIP and RR, neonates on PCV had 6% higher average TcpCO 2 , 7% higher FIO 2 , 27% higher average Edi Peak, 20% lower TV and 13% lower Edi min. Neonates on PCV ventilated with 19% lower compliance than when in NAVA. There was no difference in the number of desaturations and bradycardias in NAVA (3.7±2.5 events per 4 h) versus PCV (4.1 ± 4.2 events per 4 h). No neonate required an increase in the minimum rate when in PCV. When neonates had no Edi signal for more than 5 s, they switched into backup mode. Overall, neonates went into backup 10 ± 12 times per 4-h NAVA period. Three neonates switched into backup an average of twice per NAVA period. One neonate averaged 13 and one neonate averaged 32 switches to backup per NAVA period. Figure 1 shows the averages over each 4-h period for all the variables measured. There was an increase in PIP, TcpCO 2 , Edi peak, RR and FiO 2 each time the neonate was changed from NAVA to PCV, and all decreased again when the neonate was placed back on NAVA. In each PCV trial, the PIP was increased 2-4 times over the first 30 min (owing to TcpCO2 being 460) and then was stable throughout the rest of the 4-h period. Compliance, TV and Edi min all decreased when the patient was changed from NAVA to PCV and increased again when returned to NAVA. There was no difference in MAP between NAVA and PCV. DISCUSSION This is the first study to compare NAVA with PCV in very-low-birthweight neonates over a prolonged period of time. Lee et al. 12 reported a randomized crossover trial comparing 4 h of NAVA with PSV and showed that preterm neonates ventilated on NAVA with lower pressures and decreased work of breathing. Beck et al. 6 reported improved patient-ventilator interaction in low-birthweight neonates during the last minute of a 20-min trial of NAVA.Breatnach et al. 5 observed improved patient-ventilator synchrony during a 4-h trial of NAVA in children aged 2 days to 4 years. Bengtsson et al.
8 evaluated 30-min study periods on NAVA in 21 children undergoing congenital heart surgery (but only four were under 1 month of age and none were premature) and found that patients ventilated on NAVA had lower peak pressures and higher RR than those on PSV. Alander et al. 9 showed improved synchrony with NAVA in a crossover trial in neonatal and pediatric patients on comparing flow, pressure and NAVA-triggered ventilation. Their study compared each mode for only 10 min and the youngest patient was of 30 weeks gestation. Bordessoule et al. studied 10 infants ranging from 0.75 to 7 months on mechanical ventilation for a variety of reasons. During the 5 min of study time, PCV and PSV failed to trigger the ventilator in 4% and 6.5% of neural efforts, respectively, versus none with NAVA, trigger delays were longer in PCV and PSV than with NAVA, and the ventilator cycled off before the end of neural inspiration sooner in PCV and PSV than in NAVA. Asynchrony of the neural breath cycle with the ventilator was higher in PCV and PSV than in NAVA. 11 We have shown in a retrospective study that neonates o1500 g ventilated with NAVA had lower PIP and FiO 2 and improved blood gases compared to synchronized intermittent mandatory ventilation PCV with PSV and that this improvement was sustained over 24 h. 13 In this study, PCV was chosen as the comparison to NAVA, since PCV assists every spontaneous breath, using a flow trigger, and provides more support than synchronized intermittent mandatory ventilation PCV with PSV. We felt that PCV was a better comparison to NAVA because NAVA also assists each breath. Although the investigators set the PIP on PCV mode, the patients still determined their own RR (by using the flow trigger) and were assisted with the preset pressure for each spontaneous breath. During the study, these neonates received more support in conventional ventilation than they typically would have with synchronized intermittent mandatory ventilation PCV with PSV, and yet in NAVA they still had lower PCO 2 and better compliance and TV. When in PCV, a permissive hypoventilation strategy was followed. The initial PIP was determined by the average PIP during the last 30 min on NAVA, and adjusted only if the PCO 2 was o55 or 460 mm Hg. All neonates required increase in their PIP on PCV. This was consistent with previous studies showing lower PIP when ventilating in NAVA. 5, 12, 13 The Edi signal was an observed value when in PCV and was not used by the ventilator to determine PIP.
The higher Edi peak noted in PCV was consistent with an increased respiratory drive due to the higher PCO 2 levels. These results confirm the retrospective observations about NAVA ventilating with lower PIP and FiO 2 resulting in better blood gases previously made in neonates o1500 g. 13 These results agree with Lee's findings of decreased PIP in NAVA compared to PSV. However, that study did not show any improvement in blood gases most likely because those neonates were not very sick and had normal blood gases on PSV. 12 In contrast, neonates in this study were intentionally ventilated with PCV using a permissive hypercarbic strategy to allow higher PCO 2 levels. When in NAVA, patients had higher TV despite having lower PIP resulting in increased compliance. Lee 12 also showed a small improvement in compliance on NAVA, but this did not reach statistical significance. Alander had shown that neonates ventilated with NAVA were synchronous 91% of the time compared with 67% with pressure and 69% with flow-triggered ventilation. 9 Breatnach showed that neonates and children had improved synchrony for both triggering and breath termination, with the neural trigger compared to the pneumatic trigger of À 1 cm H 2 O. 5 Bordessoule 11 demonstrated superior synchrony of NAVA compared to PCV and PSV for neural efforts failing to trigger the ventilator, and trigger delays and neural breath cycle. This improvement in synchrony when in NAVA could account for the improved compliance and increases in TV resulting in increased CO 2 removal seen in this study. These changes further reinforce the notion that synchronous ventilation may decrease lung trauma and help prevent lung injury. 16 Another possible contributing factor for improved CO 2 removal may be changes in differential lung ventilation and perfusion with spontaneous breathing. Studies in pigs with induced lung injury and adult patients with acute respiratory distress syndrome have shown that assisted mechanical ventilation that allows spontaneous breathing resulted in increased ventilation of aerationdependent lung tissue and recruitment of atelectatic areas and redistribution of pulmonary blood flow. [17] [18] [19] [20] [21] [22] We speculate that these neonates utilized spontaneous respiration to vary their peak pressures breath to breath to recruit non aerated lung tissue and to redistribute blood flow as needed to optimize VQ matching.
MAP was unchanged between NAVA and PCV. The main determinants of MAP are PIP, RR, PEEP and inspiratory time. Although PIP and RR were lower on NAVA, the other contributors to MAP, such as inspiratory time or PEEP, must have been altered, cancelling out any lowering of MAP expected when in NAVA. Although measurement and recording of inspiratory times are not possible on the Servo-I, the Edi min was measured as a determinant of intrinsic PEEP. Edi min is the electrical activity generated by the diaphragm to maintain end expiration lung volume. It determines the tonic activity of the diaphragm and prevents derecruitment. 4, 23 Edi min was higher in NAVA, suggesting that these neonates were generating higher PEEP to maintain lung recruitment. This would result in increased MAP and cancel out any decrease in MAP that may have resulted from lower PIP and RR in NAVA.
The TV range of 2.4 À 3 ml kg À 1 in this study was lower than the previously reported spontaneous mean TVs in neonates of 6.6 ml kg À 1 (range 5.3-8.7 ml kg À 1
). 5, 6, 8, 9, 11, 12, 24 In studies of preterm neonates comparable to our study population, previous investigators reported a mean TV of 4.6 ml kg À 1 on conventional ventilation 6 and one study reported a mean TV range of 8.6 ml kg
This wide variation in TV between studies may reflect differences in acuity of neonatal respiratory lung disease or may represent variability in air leaks around the uncuffed endotracheal tube. There was no difference in the amount of desaturations and bradycardia seen, regardless of mode of ventilation. When a patient is apneic on PCV, the ventilator continues to deliver the minimum set rate. However, in NAVA, when the patient becomes apneic, the ventilator goes into backup mode and reverts to PCV. This study was done with the first NAVA software and required operator intervention to put the patient back in NAVA after the Edi signal returned. This occurred infrequently during the study and the patients were on PCV for less than 3 min total during any 4-h period on NAVA. New software updates allow the patient to cycle between NAVA and backup and return automatically to NAVA when the Edi signal resumes.
Limitations of this study include the apparent small number of subjects and the lack of long-term outcome data. We used each subject as their own control to evaluate if the results were reproducible, as each subject transitioned between NAVA and PCV three times. Using this repeated crossover design, we were able to evaluate 15 transitions between NAVA and PCV and 10 transitions between PCV and NAVA. The total amount of study time for each mode of ventilation was similar to Lee's study, which enrolled more patients but only did one crossover per patient. 12 Because the results in the current study were consistent, both between subjects and within each subject, it was felt that this number of subjects and crossovers were adequate to demonstrate a difference between these modes. Long-term outcome data were not evaluated because each neonate in this study was exposed to both modes of ventilation during their clinical course. Therefore it would be impossible to determine which mode of ventilation resulted in the prevention or development of chronic lung disease. Randomized, multicenter trials are needed to determine the impact of NAVA on long-term respiratory outcomes. Finally, although there were no adverse events noted during this study, this is a single-center pilot study that was not powered to interpret adverse events.
CONCLUSION
This study shows that very small, sick, premature neonates, ventilated with NAVA, repeatedly required less PIP, FiO 2 and RR to achieve lower PCO 2 and better compliance and TV compared with PCV NAVA proved to be at least as effective and safe as conventional ventilation in the short term. Large studies are needed to show if the use of NAVA can change the long-term outcome of these neonates. These findings are encouraging as to the future utility of NAVA in premature babies as an alternative method of ventilation with the potential to create less acute and chronic lung injury.
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